Phase II trial of etoposide, doxorubicin (Adriamycin), and cisplatin (EAP regimen) in advanced gastric cancer.

Ten previously untreated patients with gastric cancer were treated with etoposide, 120 mg/m2 intravenously (i.v.) on days 4, 5, and 6, Adriamycin, 20 ...
397KB Sizes 0 Downloads 0 Views
Download PDF

Recommend Documents

Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: results of a phase II trial.
Etoposide, adriamycin, and cisplatinum (EAP) combination chemotherapy for advanced gastric cancer. A phase II trial by the "Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)".
Phase II trial of cisplatin, adriamycin, and etoposide for metastatic endometrial adenocarcinoma.
EAP in advanced gastric cancer.
Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric cancer: an old lesson revisited.
FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.
Phase II trial of etoposide (V), adriamycin (A), and cisplatinum (P) in patients with metastatic gastric cancer.
Association of epirubicin, etoposide and cisplatin in gastric cancer. A phase II study.
Phase II trial on cisplatin-adriamycin-paclitaxel combination as neoadjuvant chemotherapy for locally advanced cervical adenocarcinoma.
A phase II trial of intraperitoneal cisplatin and etoposide for primary treatment of ovarian epithelial cancer.

Follow Us

Copyright © 2024 D.DOCKSCI.COM. All rights reserved. | Design by w3layouts